FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely oncology, and can be used for screening of probability of presence of breast cancer (BC) in patients of Caucasian race. Level of biomarkers in a biological fluid sample obtained in a subject is measured: CYFRA.21.1, ApoA2, Ddimer, HE4, B2M, ApoA1, sVCAM.1, CA125, CA15.3, TTR, hsCRP, CEA. Set of obtained values of biomarkers is processed using at least one classification model trained to determine a high or low probability of the presence of breast cancer.
EFFECT: method provides higher accuracy of screening detection of cancer in the patients of the Caucasian race by using a classification model trained to determine the high or low probability of the presence of breast cancer.
4 cl, 9 dwg, 4 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR EARLY DIAGNOSIS OF LUNG CANCER | 2018 |
|
RU2697971C1 |
| SYSTEM AND METHOD FOR SCREENING THE PROBABILITY OF HAVING COLORECTAL CANCER | 2018 |
|
RU2698854C1 |
| METHOD FOR SCREENING PROBABILITY OF BLADDER CANCER | 2019 |
|
RU2718284C1 |
| METHOD FOR SCREENING PROBABILITY OF KIDNEY CANCER | 2023 |
|
RU2816798C1 |
| METHOD OF APPLYING INFORMATION ON A COMPLEX GROUP OF BIOMARKERS FOR DIAGNOSING A MALIGNANT LUNG TUMOR IN SUBJECT, DIAGNOSTIC KIT AND COMPUTER SYSTEM USING IT | 2017 |
|
RU2687578C2 |
| METHOD FOR DIAGNOSTICS OF LUNG CANCER | 2021 |
|
RU2784356C1 |
| METHOD OF ASSESSING THE RISK OF THYROID CANCER IN PATIENTS WITH NODULAR GOITER SYNDROME | 2023 |
|
RU2814933C1 |
| METHOD FOR STABILIZING IMPLANT DURING RECONSTRUCTIVE PLASTIC SURGERY IN PATIENTS WITH BREAST CANCER | 2023 |
|
RU2811656C1 |
| METHOD FOR ASSESSING THE RISK OF THYROID CANCER IN A PATIENT WITH NODULAR THYROID FORMATIONS | 2019 |
|
RU2725749C1 |
| METHOD OF NON-INVASIVE DIAGNOSIS OF BLADDER CANCER BASED ON DETECTION OF TUMOR DNA IN BIOLOGICAL FLUIDS AND SET OF REAGENTS FOR ITS IMPLEMENTATION | 2023 |
|
RU2813669C1 |
